Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APRE
DateTimeSourceHeadlineSymbolCompany
05/14/20247:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
05/14/20247:35AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
02/06/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
02/04/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
02/02/20243:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
01/26/20246:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
01/26/20245:03AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
01/04/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/09/20233:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
11/09/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/09/20233:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
10/16/20234:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
10/13/20236:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
09/11/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
08/24/20238:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
08/24/20238:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
08/24/20238:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
08/24/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
08/10/20236:39AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
08/10/20236:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
07/11/20236:40AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
07/11/20236:30AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
07/05/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
06/14/20237:00AMGlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
06/08/20233:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
05/30/20237:30AMGlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
05/15/20233:48PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
05/15/20233:40PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
05/15/20233:05PMGlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
05/08/20234:16PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APREAprea Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APRE